BA9 clinical trials

Biosensors, unlike most of its competitors, is a drug-eluting stent (DES) manufacturer that has designed and developed a proprietary drug, (Biolimus A9™, BA9™) specifically for use in localized or targeted therapies such as on a coronary stent. These Phase I BA9 PK clinical trials were conducted as a part of a suite of non-clinical and clinical investigations to establish the safety profile and utility of BA9™ drug in vasculature by measuring key pharmacokinetic parameters.

Biosensors’ is committed to using pioneering technology in its portfolio of products, which are designed to deliver better patient outcomes.

Phase 1 Single Ascending Dose trial N=28

Design: Randomized, double blind, placebo controlled study of BA9™ with a 30 day follow-up.

Primary Endpoint: Safety, tolerability and dose dependant pharmacokinetics (PK).

Phase 1 Multiple Ascending Dose N=19
Design: Randomized, double blind, placebo controlled study of BA9™ with a 30 day follow-up.

Primary Endpoint: Safety, tolerability and dose dependant pharmacokinetics (PK).


CAUTION: The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology and endovascular products, including BioMimics 3D™, BioMatrix Flex™, BioMatrix Flex™BTK, BioMatrix NeoFlex™, BioMatrix™, Axxess™, BioFreedom™, Chroma™, BioStream™, BioPath™, Gazelle™, Juno™, S-Stent™, Powerline™, Quadrature Link™ and MultiPleat™, are not available for sale in the United States and certain other countries. All other trademarks are the property of their respective owners.

BioMatrix Flex, BioMatrix Flex BTK, BioMatrix NeoFlex, BioMatrix, Axxess, BioFreedom, Chroma, BioStream, BioPath, Gazelle, Juno, S-Stent, Powerline, Quadrature Link, MultiPleat, Accutrans, Biotrans and SafetyWedge are trademarks or registered trademarks of Biosensors International Group, Ltd. in the United States and certain other countries. BioMimics 3D and other cited trademarks are the property of their respective owners.